Department of Oncology, Affiliated Hospital of Weifang Medical University, Weifang, China.
Jinming Yu Academician Workstation of Oncology, Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
Bioengineered. 2022 Feb;13(2):2536-2552. doi: 10.1080/21655979.2021.2018235.
Heat shock factor 1 (HSF1) has watershed significance in different tumors. However, the roles and driving forces for HSF1 in colorectal cancer (CRC) are poorly understood. Our study integrally analyzed the roles and driving forces for HSF1 in CRC by bioinformatics and experiments. The expression and prognostic characteristics of HSF1 were analyzed via UALCAN, GEPIA2, TISIDB, Prognoscan and HPA databases. Then, we analyzed the correlation between HSF1 expression and immune features via TIMER2 database. Subsequently, we explored the driving forces for HSF1 abnormal expression in CRC by bioinformatics and experiments. Our results showed that HSF1 was overexpressed and correlated with poor prognosis in CRC. And the expression of HSF1 was significantly correlated with multiple immune cell infiltration and was negatively correlated with immunomodulators such as programmed cell death 1 ligand 1(PD-L1). Along with many driver genes in particular , super-enhancer, miRNA and DNA methylation were all responsible for HSF1 overexpression in CRC. Moreover, we demonstrated that β-catenin could promote the translation process of HSF1 mRNA by interacting with HuR, which could directly bind to the coding sequence (CDS) region of HSF1 mRNA. Collectively, HSF1 may be useful as a diagnostic and prognostic biomarker for CRC. HSF1 was closely correlated with immune features. Genetic and epigenetic alterations contributed to HSF1 overexpression in CRC. More importantly, we demonstrated that HSF1 may be regulated at the level of mRNA translation by β-catenin-induced HuR activity.
热休克因子 1(HSF1)在不同的肿瘤中具有分水岭意义。然而,HSF1 在结直肠癌(CRC)中的作用和驱动因素仍知之甚少。我们通过生物信息学和实验综合分析了 HSF1 在 CRC 中的作用和驱动因素。通过 UALCAN、GEPIA2、TISIDB、Prognoscan 和 HPA 数据库分析了 HSF1 的表达和预后特征。然后,我们通过 TIMER2 数据库分析了 HSF1 表达与免疫特征的相关性。随后,我们通过生物信息学和实验探索了 CRC 中 HSF1 异常表达的驱动因素。我们的研究结果表明,HSF1 在 CRC 中过表达,并与不良预后相关。并且 HSF1 的表达与多种免疫细胞浸润显著相关,与免疫调节剂如程序性细胞死亡 1 配体 1(PD-L1)呈负相关。与许多特定的驱动基因一样,超级增强子、miRNA 和 DNA 甲基化都导致了 CRC 中 HSF1 的过表达。此外,我们证明 β-连环蛋白可以通过与 HuR 相互作用来促进 HSF1 mRNA 的翻译过程,HuR 可以直接结合 HSF1 mRNA 的编码序列(CDS)区域。总之,HSF1 可能是 CRC 的一种有用的诊断和预后生物标志物。HSF1 与免疫特征密切相关。遗传和表观遗传改变导致 CRC 中 HSF1 的过表达。更重要的是,我们证明 HSF1 可能通过 β-连环蛋白诱导的 HuR 活性在 mRNA 翻译水平上受到调节。